Decheng Capital
decheng.com Direct investor
Decheng Capital is a global life sciences investment firm founded in 2012, managing over $2.5 billion in assets. It invests in early-stage life science companies and growth-stage healthcare companies.
Decheng Capital is a venture capital firm headquartered in Menlo Park, United States, founded in 2012. It invests directly in companies, from seed to growth, in life sciences, healthcare, biopharma and diagnostics and tools. Over $2.5 billion under management, as it reports.
“Decheng Capital is an investment firm that provides capital and strategic support to early-stage life science companies with revolutionary technologies and growth stage healthcare companies with strong market presence.”
— Decheng Capital, own website
- Layer
- Direct investor
- Type
- Venture capital
- Headquarters
- Menlo Park, United States
- Invests in
- global
- Sectors
- life sciences, healthcare, biopharma, diagnostics and tools, medical device, services
- Founded
- 2012
- Assets under management
- Over $2.5 billion
Team, as Decheng Capital publishes it
- Min Cui, Ph.D. Founder and Managing Director
- Victor Tong, Jr. Managing Director
- Peter Colabuono Managing Director
- Dayton Misfeldt Partner
- Tony Tong, Ph.D. Partner
- Qiang Xu, Ph.D. Partner
- Wei Xu Partner
- Aaron Li, MBA Principal
- Shengyang Jin, Ph.D. Vice President
- Michael Notaras, Ph.D. Vice President
- Joan Chen, Ph.D. Vice President
- Claire Zhang, M.B.A. Senior Associate
Names and roles exactly as listed on decheng.com. Nothing else about these people is recorded.
Co-invests most often with
Derived from portfolio pages both investors publish themselves: each pair below lists at least one company in common. 38 co-investors found.
- Foresite Capital 4 shared companies: grail.com, cgoncology.com, arcusbio.com, cuehealth.com
- LAV Advanced Management Company Limited 4 shared companies: impacttherapeutics.com, lynkpharma.com, ternspharma.com, 3sbio.com
- Longitude Capital 3 shared companies: nalumed.com, cgoncology.com, polaresmedical.com
- OrbiMed 3 shared companies: adelabio.com, ak-medical.net, upstreambio.com
- B Capital 2 shared companies: grit-bio.com, nalumed.com
- Endeavour Vision SA 2 shared companies: nalumed.com, polaresmedical.com
- SV Angel 2 shared companies: grail.com, mammoth.bio
- 8VC 2 shared companies: mammoth.bio, cellares.com
- Camford Capital Management, LLC 2 shared companies: mammoth.bio, cgoncology.com
- Mission BioCapital 2 shared companies: mammoth.bio, shapetx.com
and 28 more — the graph.
Where this comes from
Every fact above was read from a page Decheng Capital publishes itself. Nothing is taken from third-party databases. Investment activity (deals, co-investors) is not yet recorded.
- http://www.decheng.com/name, is_investor, layer, type, hq_country, hq_city, invests_in_geographies, stage_min, stage_max, sectors, thesis_quote, thesis_quote_page, description, founded, aum, status, confidence
- http://www.decheng.com/team.htmlpeople
Is this record wrong or stale? Report a mistake — it reaches us directly, no email address to look up.
Record 4984 · added 2026-09-03 · link last verified 2026-09-06 · confidence high
Similar investors
- Aisling Capital Management LPVenture capital · Seed – Growth · New York, United States
- InVivium CapitalVenture capital · Seed – Growth · Chicago, United States
- Telegraph Hill PartnersVenture capital · Growth · San Francisco, United States
- 8VCVenture capital · Seed – Growth · Austin, United States
- Alta PartnersVenture capital · San Francisco, United States
- ARCH Venture PartnersVenture capital · Seed – Growth · Chicago, United States